“Ocrelizumab-Induced Psoriasis in A Patient With Relapsing-Remitting Multiple Sclerosis”. 2023. European Journal of Medical and Health Sciences 5 (3): 1-2. https://doi.org/10.24018/ejmed.2023.5.3.1697.